, Volume 32, Issue 10, pp 716–723 | Cite as

A single major gene controls most of the difference in susceptibility to streptozotocin-induced diabetes between C57BL/6J and C3H/HeJ mice

  • K. Kaku
  • J. McGill
  • M. Province
  • M. A. Permutt


To assess genetic factors determining sensitivity to streptozotocin-induced diabetes in inbred strains of mice, a genetic analysis of streptozotocin-sensitive C57BL/6J and streptozotocin-resistant C3H/HeJ mice was performed. One week after a single dose of streptozotocin (200 mg/kg body weight), differences in plasma glucose concentration were marked between male mice of the C57BL/6J and C3H/HeJ strains (p<0.001). To determine the number of genes responsible for the difference, F1 male progeny of a cross between parental strains were produced, and found to be streptozotocin resistant like C3H/HeJ parents. F1 mice were, therefore, backcrossed with streptozotocin-sensitive C57BL/6J mice (Backcross: F1♂ ♂ X C57BL/6J ♀ ♀). The plasma glucoses of backcrossed male mice (n=41) following streptozotocin treatment appeared to segregate into two populations, half like the C57BL/6J parent, and half like the F1 parent. Statistical analysis of the data revealed that the data fit a model with two distributions better than one with a single distribution, suggesting a single major gene responsible for the difference in streptozotocin susceptibility. This hypothesis was also supported by the observation that streptozotocin sensitivity in 12 recombinant inbred strains of C57BL/6J and C3H/HeJ mice appeared to segregate into two classes. Resistance to streptozotocin induced diabetes in F1 mice suggested that the expression of this gene is recessive, although X-chromosome linked inheritance could not be excluded.

Efforts to map the streptozotocin-sensitivity gene revealed lack of right linkage to several loci including the H-2 locus. If inherited differences in the ability to resist a B-cell toxin play a role in genetic susceptibility to diabetes in man, then mapping the streptozotocin-susceptibility gene in mice may provide a means to evaluate the role of a putative homologous locus in the aetiology of diabetes in man.

Key words

Streptozotocin diabetes-susceptibility genetic analysis inbred mouse strains H-2 locus 


  1. 1.
    Junod A, Lambert AE, Orci L, Piltet R, Gonet AE, Renold AE (1967) Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med 129: 201–205Google Scholar
  2. 2.
    Like AA, Rossini AA (1976) Streptozotocin-induced pancreatic insulitis; new model of diabetes mellitus. Science 193: 415–417Google Scholar
  3. 3.
    Rossini AA, Appel MC, Williams RM, Like AA (1977) Genetic influence of the streptozotocin-induced insulitis and hyperglycemia. Diabetes 26: 916–920Google Scholar
  4. 4.
    Like AA, Appel MC, Williams RM, Rossini AA (1978) Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies. Lab Invest 38: 470–486Google Scholar
  5. 5.
    Lewis C, Barbiers AR (1959) Streptozotocin, a new antibiotic. In vitro and in vivo evaluation. Antibiot Ann pp 247–254Google Scholar
  6. 6.
    Varva JJ, DeBoer C, Dietz A, Hanka LJ, Sokolski WJ (1959) Streptozotocin, a new antibacterial antibiotic. Antibiot Ann pp 230–235Google Scholar
  7. 7.
    White FR (1963) Streptozotocin. Cancer Chemother Rep 30: 49–53Google Scholar
  8. 8.
    Rakieten N, Rakieten ML, Nadkarni MV (1963) Studies of the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 29: 91–98Google Scholar
  9. 9.
    Lown JW, McLaughlin LW, Chang Y-M (1978) Mechanism of action of 2-haloethyl nitrosoureas on DNA and its relation to their antileukemic properties. Bioorg Chem 7: 97–110Google Scholar
  10. 10.
    Dulin WE, Wyse BM (1969) Studies of the ability of compounds to block the diabetogenic activity of streptozotocin. Diabetes 18: 459–466Google Scholar
  11. 11.
    Shein PS, Cooney DA, Vernon ML (1967) The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumoral activity. Cancer Res 27: 2324–2332Google Scholar
  12. 12.
    Anderson T, Shein PS, McMenamin MG (1974) Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide. J Clin Invest 54: 672–677Google Scholar
  13. 13.
    Leiter EH (1985) Differential susceptibility of BALB/c sublines to diabetes induction by multi-dose streptozotocin treatment. Curr Top Microbiol Immunol 122: 78–85Google Scholar
  14. 14.
    Rossini AA, Williams RM, Appel MC, Like AA (1978) Sex differences in the multiple-dose streptozotocin model of diabetes. Endocrinology 103: 1518–1520Google Scholar
  15. 15.
    Maclaren NK, Neufeld M, McLaughlin JV, Taylor G (1980) Androgen sensitization of streptozotocin-induced diabetes in mice. Diabetes 29: 710–716Google Scholar
  16. 16.
    Paik S, Michelis MA, Kim YT, Shin S (1982) Induction of insulin-dependent diabetes by streptozotocin: inhibition by estrogens and potentiation by androgens. Diabetes 31: 724–729Google Scholar
  17. 17.
    Kiesel U, Kolb M (1982) Low-dose streptozotocin-induced autoimmune diabetes is under the genetic control of the major histocompatibility complex in mice. Diabetologia 23: 69–71Google Scholar
  18. 18.
    Kiesel U, Falkenberg FW, Kolb H (1983) Genetic control of low- dose streptozotocin-induced autoimmune diabetes in mice. J Immunol 130: 1719–1722Google Scholar
  19. 19.
    Wolf J, Lilly F, Shin S (1984) The influence of genetic background on the susceptibility of inbred mice to streptozotocin-induced diabetes. Diabetes 33: 567–571Google Scholar
  20. 20.
    Le PH, Leiter EH, Leyendecker JR (1985) Genetic control of susceptibility to streptozotocin diabetes in inbred mice: effect of testosterone and H-2 haplotype. Endocrinology 116: 2450–2455Google Scholar
  21. 21.
    Kromann H, Christy M, Egeberg J, Lernmark Å, Nerup J (1982) Absence of H-2 genetic influence on streptozotocin-induced diabetes in mice. Diabetologia 23: 114–118Google Scholar
  22. 22.
    Leiter EH, Le PH, Coleman DL (1987) Susceptibility to db gene and streptozotocin-induced diabetes in C57/BL mice: control by gender-associated, MHC-unlinked traits. Immunogenetics 26: 6–13Google Scholar
  23. 23.
    Bailey DW (1981) Recombinant inbred strains and bilineal congenic strains. In: Foster HL, Small JD, Fox JF (eds) The mouse in biomedical research, Vol I. Academic Press, New York, pp 223–239Google Scholar
  24. 24.
    Kaku K, Fiedorek FT Jr, Province M, Permutt MA (1988) Genetic analysis of glucose tolerance in inbred strains of mice: evidence for polygenic control. Diabetes 37: 707–713Google Scholar
  25. 25.
    Passmore HC, Kobori JA, Zimmerer EJ, Spinella DG, Hood L (1987) Molecular characterization within the major histocompatibility complex of the mouse: mapping of crossover sites within the I region. Biochem Genetics 25: 513–523Google Scholar
  26. 26.
    Morton NE, Rao DC, Lalouel JM (1983) Methods in genetic epidemiology. Karger, Basle New York Tokyo Sydney, pp 21–23Google Scholar
  27. 27.
    Tulchin N, Taylor BA (1981) r-glutamyl cyclotransferase: a new genetic polymorphism in the mouse (mus musculus) linked to LYT-2. Genetics 99: 109–116Google Scholar
  28. 28.
    Silver J, Buckler CE (1986) Statistical considerations for linkage analysis using recombinant inbred strains and backcrosses. Proc Natl Acad Sci USA 83: 1423–1427Google Scholar
  29. 29.
    Kawada J, Toide K, Nishida M, Yoshimura Y, Tsujihara K (1986) New diabetogenic streptozotocin analogue, 3-0-methyl-2- {[(methyl-nitrosamino) carbonyl] amide}-D-glucopyranose. Evidence for a glucose recognition site on pancreatic B-cells. Diabetes 35: 74–77Google Scholar
  30. 30.
    Cooperstein SJ, Watkins D (1981) Action of toxic drugs on islet cells. In: Cooperstein SJ, Watkins D (eds) The islets of Langerhans. Academic Press, New York, pp 387–425Google Scholar
  31. 31.
    Okamoto H (1981) Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes. Mol Cell Biochem 37: 43–61Google Scholar
  32. 32.
    Yamamoto H, Uchigata Y, Okamoto H (1981) Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature 294: 284–286Google Scholar
  33. 33.
    Yamamoto H, Uchigata Y, Okamoto H (1981) DNA strand breaks in pancreatic islets by in vivo administration of alloxan or streptozotocin. Biochem Biophys Res Comm 103: 1014–1020Google Scholar
  34. 34.
    Rouer E, LeProvost E, Leroux J-P (1983) Study of benzphetamine- N-demethylase in streptozotocin-diabetic mice and rats: evidence of the induction of catalytically and immunologically specific forms of cytochrome p 450. Biochim 65: 679–683Google Scholar
  35. 35.
    Peng R, Tennant P, Lorr NA, Yang CS (1983) Alterations of microsomal monooxyganase system and carcinogen metabolism by streptozotocin-induced diabetes in rats. Carcinogenesis 4: 703–708Google Scholar
  36. 36.
    Favreau LV, Schenkman JB (1988) Composition changes in hepatic microsomal cytochrome p-450 during onset of streptozotocin-induced diabetes and during insulin treatment. Diabetes 37: 577–584Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • K. Kaku
    • 1
  • J. McGill
    • 1
  • M. Province
    • 2
  • M. A. Permutt
    • 1
  1. 1.Metabolism Division, Department of Internal MedicineWashington University School of MedicineSt. LouisUSA
  2. 2.Division of Biostatistics, Department of Preventive MedicineWashington University School of MedicineSt. LouisUSA

Personalised recommendations